The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody
Abstract
Incorporation of the serine protease active site reagent diisopropyl fluorophosphate (DFP) into a plasminogen activator with an Mr of approximately 52000 released from cultured human glioblastoma cells was strongly enhanced by incubation with plasmin. This observation led to the isolation of an inactive form of the enzyme from serum-free conditioned culture fluid by affinity chromatography on a column of a Sepharose-bound monoclonal antibody raised against urokinase. An 831-fold purification was obtained with a yield of 41%. The purified molecule was homogeneous as evaluated by polyacrylamide gel electrophoresis with sodium dodecyl sulfate (NaDodSO4), having one stainable band under nonreducing as well as reducing conditions with an Mr of approximately 52000. It was unable to activate plasminogen, but catalytic amounts of plasmin converted it into active enzyme. After NaDodSO4-polyacrylamide gel electrophoresis, the active enzyme showed one band under nonreducing conditions, but after reduction, two bands with Mr values of approximately 20000 and 32000 were observed. The active enzyme incorporated [3H]DFP into the approximately Mr 32000 band, while no incorporation was observed into the inactive form. These findings show that the Mr 52000 human plasminogen activator exists in a proenzyme form consisting of a single polypeptide chain that by proteolysis between half-cystine residues is converted into the active enzyme consisting of two chains with molecular weights of approximately 20000 and 32000, the active site being on the latter chain. The results are consistent with the active form of the enzyme being identical with the higher molecular weight form of urokinase, and together with recent observations that a murine plasminogen activator is released from sarcoma virus transformed cells as an inactive proenzyme, they suggest that zymogens to plasminogen activators are of more general occurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Plasminogen: Purification from Human Plasma by Affinity Chromatography
Deutsch, D. G., & Mertz, E. T. (1970) · Science · doi:10.1126/science.170.3962.1095 · Cited by 2,130
A study of proteases and protease-inhibitor complexes in biological fluids
Granelli-Piperno, A., & Reich, E. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.1.223 · Cited by 803
SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGES
Unkeless, J. C., Gordon, S., & Reich, E. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.4.834 · Cited by 706
Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm
Strickland, S., Reich, E., & Sherman, M. I. (1976) · Cell · doi:10.1016/0092-8674(76)90114-8 · Cited by 580
WEBER, K., & OSBORN, M. (1975) · The Proteins · doi:10.1016/b978-0-12-516301-9.50007-3 · Cited by 532
Fibrinolysis Associated with Oncogenic Transformation
Unkeless, J. C., Danø, K., Kellerman, G. M., & Reich, E. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42516-7 · Cited by 437
Ovarian plasminogen activator: Relationship to ovulation and hormonal regulation
Beers, W. H., Strickland, S., & Reich, E. (1975) · Cell · doi:10.1016/0092-8674(75)90188-9 · Cited by 433
Ossowski, L., Biegel, D., & Reich, E. (1979) · Cell · doi:10.1016/0092-8674(79)90108-9 · Cited by 422
Matsuo, O., Rijken, D. C., & Collen, D. (1981) · Nature · doi:10.1038/291590a0 · Cited by 248
Goldberg, A. R. (1974) · Cell · doi:10.1016/0092-8674(74)90097-x · Cited by 201
Christman, J. K., & Acs, G. (1974) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(74)90279-2 · Cited by 125
Cited by
Plasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535
Regulation of cell signalling by uPAR
Smith, H. W., & Marshall, C. J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2821 · Cited by 960
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
Vassalli, J. D., Baccino, D., & Belin, D. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.1.86 · Cited by 712
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Blasi, F., Vassalli, J., & Danø, K. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.4.801 · Cited by 617
Stoppelli, M. P., Corti, A., Soffientini, A., Cassani, G., Blasi, F., & Assoian, R. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4939 · Cited by 443
Metadata
- Authors
- Nielsen, L. S., Hansen, J. G., Skriver, L., Wilson, E. L., Kaltoft, K., Zeuthen, J., & Danoe, K.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1982-12-07
- Volume
- 21
- Issue
- 25
- Pages
- 6410-6415
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2000382731
- Cited by
- 257
- References
- 12
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.